The antihypertensive efficacy of esaxerenone and its good safety profile suggest that this novel MR blocker may be a promising treatment option for patients with hypertension and could be used in combination therapy regimens to achieve substantial BP reductions and a good BP control. This evidence concerns the gene NR3C2 and hypertensive disorder.